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1. Introduction  
Stem cells localize to specific sites called ‘niches’ in various tissues, where they are 
preferentially maintained by growth factors from the environment. Mammalian bone marrow 
(BM) has been shown to be relatively hypoxic compared to other tissues, and primitive 
hematopoietic cells, including hematopoietic stem cells (HSCs), are thought to localize to the 
most hypoxic microenvironments in the BM. The hypoxic ex vivo culture of BM cells or 
primitive hematopoietic progenitors results in the maintenance of the primitive phenotype 
and cell cycle quiescence (Mohyeldin et al., 2010; Suda et al., 2011). Ex vivo culture of human 
HSCs under hypoxia also stabilizes hypoxia-inducible factor-1 (HIF-1), a master 
transcriptional regulator of the cellular and systemic hypoxic response, and induces various 
downstream effectors of HIF-1 (Danet et al., 2003). However, the regulatory mechanisms and 
functional effects of BM hypoxia on HSCs in vivo have not been fully elucidated.  
In the stem cell niche, HSCs are quiescent and show slow cell cycling. Various extracellular 
ligands, including CXCL12 (Sugiyama et al., 2006), angiopoietin-1 (Arai et al., 2004), and/or 
thrombopoietin (TPO) (Qian et al., 2007; Yoshihara et al., 2007), contribute to the quiescence of 
HSCs. Quiescent HSCs are maintained at a lower oxidative stress state to avoid their 
differentiation and exhaustion (Jang & Sharkis 2007). HIF-1 is a bHLH-PAS–type 
transcription factor (Semenza, 2007, 2009, 2010). Under normoxic conditions, prolyl residues in 
the HIF-1 oxygen-dependent degradation domain (ODD) are hydroxylated by HIF prolyl 
hydroxylases (PHDs). The hydroxylated ODD domain of HIF-1 protein is recognized by an 
E3 ubiquitin ligase, the von Hippel-Lindau protein (VHL). In the autosomal dominant 
hereditary disorder von Hippel Lindau disease, VHL is mutated, resulting in overstabilized 
HIF-1 protein by the impaired ubiquitin-proteasome pathway. Under hypoxic conditions, 
PHDs are inactivated and HIF-1 protein escapes degradation. Several niche factors, such as 
thrombopoietin (TPO) (Kirito et al., 2005) and stem cell factor (SCF) (Pedersen et al., 2008), also 
stabilize HIF-1 protein in hematopoietic cells even under normoxic conditions. 
Stabilized HIF-1 protein forms a heterodimeric transcriptional complex with the oxygen-
independent subunit HIF-1, translocates to the nucleus, and directly binds hypoxia-
responsive elements found in the promoter regions of numerous downstream regulators, 
thereby activating their transcription. HIF-1 is reportedly required for hematopoietic cell 
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generation during ontogeny. However, a detailed analysis of the contribution of HIF-1to 
the maintenance of adult HSCs has not yet been reported. 
We analyzed HSCs in HIF-1– and VHL-deficient mice and found that the cellular pool and 
cell cycle status of HSCs were regulated by the HIF-1 level (Takubo et al., 2010). Our 
analysis revealed that the regulation of the HIF-1 dose is critical for HSC maintenance in 
the hypoxic niche microenvironment of the BM. The critical role for HIF-1 in HSC cell cycle 
regulation broadens the involvement of oxygen status in the stem cell niche. It also implies a 
novel strategy for maintaining and expanding HSC resources based on cellular oxygen 
metabolism reprogramming, including the modulation of HSC quiescence through the 
oxygenation status of HIF-1. 
2. Quiescence of hematopoietic stem cells 
Somatic stem cells contribute to tissue homeostasis throughout life (Suda et al., 2011). 
Because proliferation will induce senescence, the proper maintenance of stem cells without 
senescence is mandatory. There are two states for tissue stem cells in terms of the cell cycle. 
One is the quiescent state. Stem cells in the quiescent state are out of the active cell cycle 
(S/G2/M phase) and in the G0 phase. The other is the cycling state. Cycling stem cells 
actively reproduce themselves (self-renewal) to generate progeny. Cycling cells are in the 
non-G0 phase of the cell cycle. Quiescence is thought to be an effective strategy for stem 
cells to avoid various forms of cytotoxic damage. If stem cells lost quiescence, they would 
become susceptible to intrinsic and extrinsic stresses.  
Mammalian HSCs are included in the heterogeneous population of lineage marker-, Sca-1+, 
and c-Kit+ (LSK) cells. LSK cells are a mixture of progenitors and HSCs. Within the LSK 
population, CD34-CD150hiCD48-CD41-Flt3- cells, as well as side population (SP) cells (Osawa 
et al, 1996; Kiel et al, 2005; Goodell et al, 1996), are quiescent. 
Measurement of the cell cycle in HSCs by the staining of DNA with Hoechst 33342, DAPI, 
and/or anti-Ki67 indicates that more than 70% of highly purified HSC (CD34–CD48–CD150hi 
LSK) are in the G0 phase, whereas less than 10% of CD34+ LSK cells  (differentiated 
progenitors) are in the quiescent phase (Wilson et al, 2008).  
Slow-cycling HSCs have long-term (LT) reconstitution activity when they are transplanted 
into lethally irradiated recipient mice. In contrast, actively cycling HSCs and progenitors 
exhibit only short-term (ST) reconstitution activity and only maintain hematopoiesis for 3–4 
months. Thus, the former are termed “LT-HSC(s)” and the latter are “ST-HSC(s)”. LT-HSCs 
produce ST-HSCs, multipotent progenitors (MPPs), lineage-restricted progenitors, and 
terminally differentiated hematopoietic cells including erythrocytes, platelets, lymphocytes, 
granulocytes, and macrophages (Figure 1).  
Because slow-cycling stem cells are not in the S or M phase of the cell cycle, they are more 
resistant to cytotoxic agents such as ultraviolet (UV) light, ionizing radiation and chemicals, 
compared with actively cycling cells. Recent reports indicate that quiescent stem cell 
fractions are present in several tissues. For example, in the hair follicle, cell cycle progression 
of stem cells in bulge regions is suppressed by Wnt inhibitors (Fuchs and Horsley, 2011). In 
contrast, stem cells in the murine intestinal and gastric epithelia divide every 24 hours 
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(Snippert and Clevers, 2011). Therefore, quiescence itself is not the only strategy for the 
long-term maintenance of stem cells. 
  
Life-long hematopoiesis is maintained by long-term (LT)-HSCs and their progeny. LT-HSCs have a two 
cell cycle states: a quiescent state (G0 phase) and a cycling state (non-G0; i.e., G1/S/G2/M phase). LT-
HSCs in the former state are resistant to various cytotoxic stresses. Reactive oxygen species (ROS) 
change the cell cycle state of LT-HSCs from quiescent to cycling. Cycling LT-HSCs are also promoted to 
differentiate into short-term (ST)-HSCs and multipotent progenitors (MPPs). These differentiated 
progenitors actively produce various terminally differentiated hematopoietic cells. 
Fig. 1. Quiescent and cycling hematopoietic stem cells (HSCs) 
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One important regulator for the quiescence of HSCs is reactive oxygen species (ROS). 
ROS are an intrinsic and extrinsic stress for HSCs (Figure 2). Intrinsically, ROS are 
mainly produced by mitochondria, the energy factory of the cell, as a by-product of the 
electron transport chain. Because anaerobic energy metabolism in mitochondria utilizes 
oxygen to generate ATP, oxygen-rich conditions produce intracellular ROS in HSCs. In 
addition, various immune cells utilize oxygen to generate ROS as an anti-microbial 
agent. ROS have favourable and unfavourable effects on HSCs. ROS are a signal 
transducer for essential cytokine signalling in HSCs (Sattler et al., 1999). However, 
excessive or prolonged ROS exposure is detrimental to HSCs (Naka et al., 2008). 
Aberrant exposure to ROS induces senescence, apoptosis, or the accumulation of DNA 
damage in HSCs. These damaged cells are dysfunctional and a potential source for 
leukemic transformation. Therefore, it is reasonable to hypothesize that HSCs reside in a 
hypoxic microenvironment. 
 
HSCs are exposed to ROS from various sources, including endogenous mitochondria and adjacent 
immune cells. High O2 pressure in the microenvironment also promotes ROS generation. This ROS 
burden results in the oxidation of DNA, protein, and lipid in HSCs. Also, the appropriate dose of ROS 
mediates cytokine signalling in HSCs. These balances determine the fate of HSCs: survival, premature 
senescence, apoptosis, differentiation, or malignant transformation. 
Fig. 2. Intrinsic and extrinsic oxidative stresses and HSCs 
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3. Hypoxic nature of bone marrow 
Although molecular oxygen is critically important for living organisms, HSCs are 
susceptible to reactive oxygen species or oxidative stresses that are derived from molecular 
oxygen. To maintain life-long hematopoiesis, it is reasonable for HSCs to avoid high-oxygen 
conditions. Although classical observations and theoretical studies supported these views, 
experimental evidence has only been recently provided. 
Classically, bone marrow has been thought to be hypoxic. Recently, its exact nature and 
dynamic regulation were studied. This section will summarize the classical and recent 
studies related to the functional anatomy of bone marrow oxygenation. 
Genetic studies have postulated that LT-HSCs reside primarily in the endosteal zone of the 
bone marrow (BM) (Calvi et al, 2003; Zhang J, 2003; Arai et al, 2004). Vascular organization 
around the endosteal zone is unique (Draenert and Draenert, 1980). Nutrient arteries 
penetrate the cortical bone, enter the medullary canal, and then proceed in a spiral pattern 
into the metaphyseal region of the bone marrow. The blood in arterial capillaries drains into 
sinusoids, which are fenestrated and loosely organized.  
As a result, hematopoietic cells can easily move across the sinusoidal endothelium. 
Accordingly, the perfusion of the BM is limited and the partial oxygen pressure (PO2) in the 
endosteal region is very low.  
In addition to hypoperfusion, the BM is tightly packed with blood cells. Oxygen 
consumption by hematopoietic cells is relatively high, and a simulation of O2 diffusion 
in the bone marrow suggested that the PO2 is decreased 10-fold at a distance of several 
cells from the nearest capillary (Chow et al, 2001). The average PO2 in the BM is 
approximately 55 mmHg and the mean O2 saturation is 87.5% (Harrison et al, 2002). 
Thus, based on this simulation study, HSCs may well reside in a severely hypoxic 
environment.  
In support of this idea, it has also been reported that murine HSCs live in a hypoxic BM 
niche. By administering a perfusion tracer into mice, one group found that HSCs 
accumulated in a hypoperfusion cellular fraction in the BM (Parmar et al, 2007). These 
hypoperfused cells retained pimonidazole, a probe that selectively binds and forms adducts 
with protein thiol groups in a hypoxic environment. Administration of a toxin selective for 
hypoxic cells (tirapazamine) resulted in the depletion of HSCs in vivo. It was also shown that 
LT-HSCs are positive for pimonidazole in mice (Takubo et al, 2010). Moreover, human cord 
blood stem cells transplanted into super-immunodeficient NOD/scid/IL-2R (NOG) mice 
homed to the BM niche and became both hypoxic and quiescent after BM transplantation 
(Shima et al, 2010).  
Collectively, these findings suggest the hypoxic nature of HSCs. The hypoxic character of 
LT-HSCs is potentially determined by their position within the BM. However, in contrast 
to the simple O2 gradient model for the BM hypoxic niche, immunohistochemical 
observation of a two-dimensional segment of the murine BM suggests that 60% of LT-
HSCs localize closely to BM endothelial cells (Kiel et al, 2005; Sugiyama et al, 2006).  
These findings do not fit the simple O2 gradient model for the hypoxic status of HSCs in 
the niche. However, as noted above, the vasculature in the niche near the endosteal zone 
of the BM may perfuse the bone marrow very poorly. Four-dimensional tracking (time-
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lapse and three-dimensional observation with a multi-photon microscope) of single LT-
HSCs in the BM has shed light on this paradox. Real-time tracking of murine BM 
revealed that HSCs gradually move away from bone marrow blood vessels and then 
detach from them and translocate to the osteoblastic zone of the BM after transplantation 
(Lo Celso et al, 2009; Xie et al, 2009). Based on these observations, it is possible that 
subpopulations of HSCs residing in different specific locations have different 
oxygenation statuses.  
In parallel with the hypoxic microenvironment for HSCs in vivo, hypoxic culture 
phenotypically and functionally sustained HSCs more effectively than normoxic culture 
(20% oxygen). Also, hypoxic culture enhances the colony-forming ability (progenitor ability) 
and transplantation capacity (HSC capacity) of cultured BM cells or isolated HSCs 
(Cipolleschi et al, 1993; Danet et al, 2003; Ivanovic et al, 2004). Hypoxic treatment also 
induces cell cycle quiescence in cultured HSC (Hermitte et al, 2006; Shima et al, 2010). 
Quiescent HSCs are defined by a high amount of efflux of the DNA-binding dye Hoechst 
33342 from the cytosol (Goodell et al, 1996). These cells are called “side population (SP)” 
cells due to their specific staining pattern by flow cytometric analysis. Hypoxic treatment 
also sustains the SP phenotype in HSC in vitro (Krishnamurthy et al, 2004). Exclusion of 
Hoechst dye from the HSC cytosol is supported by Bcrp1/ABCG2, an ATP-dependent 
transporter, at the plasma membrane. When HSCs were cultured under hypoxic conditions, 
mRNA expression of Bcrp1/ABCG2 was significantly increased and the number of SP cells 
was also increased as compared to HSCs cultured at normoxia. Interestingly, because Bcrp1-
/- mice show no significant defect in hematopoiesis (Zhou et al, 2001), the functional role of 
Bcrp1 in HSCs is still uncharacterized. 
4. Hypoxia response system in HSCs 
Cells sense, respond, and adapt to hypoxia using hypoxia-responsive regulatory pathways. 
HSCs utilize the same hypoxia response pathways as a number of other cell types. A central 
component of these pathways is hypoxia-inducible factor-1 (HIF-1), a transcription factor 
that is essential for cellular and systemic responses to a low oxygen microenvironment 
(Semenza, 2010) (Figure 3). HIF-1 is a heterodimeric transcription factor consisting of the 
oxygen-dependent HIF-1 subunit and an oxygen-independent HIF-1 subunit (Wang and 
Semenza, 1995). HIF-1 is hydroxylated at proline (Pro) 402 and/or 564 in the oxygen-
dependent degradation (ODD) domain under normoxic conditions (Kaelin and Ratcliffe, 
2008). HIF-1 is hydroxylated by three prolyl hydroxylases (PHD1–3) which require 
molecular oxygen, Fe2+, 2-oxoglutarate, and ascorbic acid for their full enzymatic activity 
(Epstein et al, 2001). Prolyl-hydroxylated HIF-1 protein is recognized by the von Hippel-
Lindau (VHL) tumor suppressor protein, which recruits the Elongin C/Elongin 
B/Cullin2/E3 ubiquitin ligase complex. As a result, prolyl-hydroxylated HIF-1 protein is 
ubiquitinated and degraded by the proteasome. Under a hypoxic environment, prolyl 
hydroxylases lose their enzymatic activity. Thus, prolyl hydroxylation of HIF-1 is 
suppressed, and HIF-1 protein is stabilized without degradation (Kaelin and Ratcliffe, 
2008). HIF-1 heterodimers (HIF-1:HIF-1) are recruited and bind to hypoxia response 
elements (HREs) in various target genes and activate transcription programs (Semenza, 
2010).  
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The diagrams represent the regulation of HIF-1 protein and interacting factors under different oxygen 
conditions. HIF-1 is a substrate for both prolyl and asparaginyl hydroxylases. Under normoxia, 
proline and asparagine residues are hydroxylated. These modifications regulate the stability and 
transcriptional activity of HIF-1. bHLH, basic-helix-loop-helix domain; PAS, Per-ARNT-Sim domain; 
TAD-N, transactivation domain N-terminal; ID, inhibitory domain; TAD-C, C-terminal transactivation 
domain; PHD, prolyl hydroxylase domain-containing protein; and FIH-1, factor-inhibiting HIF-1. 
 
 
 
 
Fig. 3. Regulation of hypoxia-inducible factor-1 (HIF-1) 
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Scheme of biological outcomes of different HIF-1 protein levels in HSCs. This is achieved by HIF-1 or 
VHL deletion in HSCs using knockout mouse models. Normal HSCs (the second from the top) stabilize 
HIF-1, which maintains cell cycle quiescence at the hypoxic bone marrow niche in the endosteum. 
Preferential stabilization of HIF-1 was observed in HSCs under hypoxia. HIF-1 HSCs (top) lose cell 
cycle quiescence and stress resistance against transplantation, chemotherapeutic agents, and aging. In 
addition, HIF-1 HSCs leave the bone marrow niche and drive extramedullary hematopoiesis in the 
spleen. Production of ROS is accelerated in HIF-1 HSCs. Heterozygous deletion of VHL results in a 
slight increase in HIF-1 protein. Under these conditions, cell cycle quiescence in HSCs is enhanced. The 
VHL+/ HSC (the second from the bottom) is resistant to transplantation and aging. ROS production is also 
suppressed in VHL+/ HSCs. The homozygous VHL mutant (VHL) HSC has a maximal dose of HIF-1 
protein. In contrast to heterozygous VHL mutant HSCs, VHL HSCs completely lost stem cell capacity 
potentially due to aberrant suppression of the cell cycle and/or homing capacity to the niche. This defect is 
HIF-1–dependent because the co-deletion of HIF-1 in homozygous VHL-deficient hematopoietic cell 
rescued the defect. Thus, the precise regulation of HIF-1 levels coordinates stem cell proliferation and 
differentiation. Recently, it has been reported that vascular endothelial growth factor, heat shock proteins, 
and GRP78 and its ligand Cripto regulate HSC quiescence and maintain HSCs in hypoxia as downstream 
factors of HIF-1 (Rehn et al, 2011; Miharada et al, 2011).  
Fig. 4. Features of HIF-1 or VHL knockout HSCs 
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HIF-1 mRNA and protein are highly expressed in LT-HSCs (Takubo et al, 2010; Simsek et 
al, 2010) (Figure 4). HSCs derived from conditional HIF-1 knockout (HIF-1) mice have a 
defective capacity for marrow reconstitution during serial BM transplantation (Takubo et 
al., 2010). HIF-1 LT-HSCs lost cell cycle quiescence, entered the cell cycle from G0 phase, 
proliferated, and showed reduced tolerance to stresses such as 5-fluorouracil administration 
or aging. These studies suggest that HIF-1 plays an essential role in the regulation of HSC 
quiescence and stress resistance in vivo. In addition to these HIF-1 loss-of-function studies, 
conditional deletion of the VHL gene in hematopoietic cells was performed as a HIF-1 
gain-of-function experiment. Analysis of VHL mutant hematopoietic cells revealed that the  
functional properties of LT-HSCs and progenitors are differentially influenced by HIF-1. 
HIF-1 protein levels are elevated in either biallelic (VHL) or monoallelic (VHL+) 
conditional knockout hematopoietic cells. For example, only a minor population of normal 
hematopoietic progenitors (CD34+ LSK cells) are in a quiescent state. In clear contrast, the 
proportion of VHL+/ hematopoietic progenitors in the quiescent phase is significantly 
higher. At steady state, HIF-1 protein levels are not high in hematopoietic progenitors, and 
forced stabilization of HIF-1 protein through monoallelic VHL deletion induces VHL+/ 
CD34+ LSK progenitors to exit the cell cycle and maintains them in the G0 phase. Severe 
suppression of cell cycling and transplantation capacity is restored in HIF-1:VHL 
doubly mutated HSCs. The decreased frequency of LT-HSCs seen in VHL mice is rescued 
by the co-deletion of the HIF-1 gene in vivo. Also, long-term in vitro exposure of LT-HSCs 
to a PHD inhibitor (dimethyloxalylglycine; DMOG), which stabilizes HIF-1α even under 
normoxic conditions, attenuates stem cell ability especially during BM transplantation 
(Eliasson P et al, 2010).  
Collectively, these results provide evidence that there is an optimal HIF-1 protein level 
for HSC maintenance. HIF-1 is required for stress resistance and long-term maintenance 
of HSCs, and within an appropriate range, moderate increases of HIF-1 (to the level 
caused by VHL heterozygous deletion) are trophic for HSCs through the induction of 
quiescence.  However, aberrantly high HIF-1 levels are also harmful to HSCs and lead to 
a loss of stem cell capacity and the exhaustion of the HSC pool. Homozygous deletion of 
VHL results in a severe suppression of the cell cycle and a homing defect during 
transplantation.  
HIF-1 not only acts in the HSC system but also plays an important role in neural stem cells 
(NSCs) under hypoxic conditions. In this type of cell, HIF-1 induces the activation of the 
Wnt/-catenin signalling pathway through the upregulation of -catenin and the expression 
of the downstream transcription factors lymphoid enhancer-binding factor 1 and T-cell 
factor 1 (Mazumdar J et al, 2010). Wnt/-catenin activity was closely correlated with 
hypoxic status in the subgranular zone of the hippocampus, which is one of the niches for 
NSCs. Loss of HIF-1 in NSCs resulted in a defective Wnt-dependent hippocampal 
neurogenic niche capacity. As a result, NSC proliferation and differentiation, and the 
production of new neurons, were attenuated. Interestingly, the biological effects of HIF-1 
on NSCs (cell cycle promotion) are clearly different from those seen in HSCs (cell cycle 
quiescence). It will be important to dissect how these different lineage stem cell systems 
utilize the same protein (HIF-1) to sustain themselves using different downstream 
molecular machinery and biological events. It is also of interest to investigate embryonic 
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HSCs, which actively proliferate in hypoxic conditions, because HIF-1 may support HSC 
proliferation in that stage. In addition, HIF-1 protein has been reported to inhibit Wnt/-
catenin activity in cancer cells (Kaidi A et al, 2007), suggesting that the interaction of the 
HIF-1 and Wnt/-catenin pathway in stem/progenitor cells may differ from that of more 
differentiated or transformed cell types. 
5. Conclusion 
In this chapter, I have summarized our current knowledge regarding the hypoxia response 
and oxygen metabolism in HSCs at the BM niche. These studies open novel fields in stem 
cell biology. The invisible niche factor, oxygen, is usually essential because mitochondria 
utilize it for the energy production. However, molecular oxygen is a source of ROS during 
mitochondrial metabolism. Because an excessive dose of ROS can be damaging to HSC, 
escape from oxygen (in the hypoxic niche) is a reasonable strategy for the long-term 
maintenance of HSCs in vivo. Adult HSCs are quiescent and contain few mitochondria, 
whereas hematopoietic progenitor cells actively proliferate and contain many mitochondria. 
Thus, stem cells and progenitors have distinct metabolic states, and the transition from stem 
to progenitor cell may correspond to a critical metabolic change, namely from glycolysis to 
oxidative phosphorylation. Slow cell cycling or long-term quiescence is common in adult 
tissue stem cells. Dormancy in the cell cycle may be a crucial mechanism for the stress 
resistance of normal and leukemic stem cells. 
Further investigation of oxygen metabolism in tissue stem cells will result in more 
effective maintenance, expansion, and manipulation of various somatic stem cells ex vivo 
and in vivo, maximizing the potential of therapeutic strategies using stem cells in 
regenerative medicine.  Also, an understanding of oxygen homeostasis in HSCs is 
essential for understanding senescence at the stem cell level as well as therapeutic 
targeting against leukemic stem cells.  
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